Government should strengthen local pharmaceutical industry's competitiveness, KPMA says

Published: 2007-05-29 06:59:00

Updated: 2007-05-29 06:59:00

The domestic market will suffer damage of 10-12 trillion won for the next five to seven years due to extension of patent period for new drugs in an era of the Korea-U.S. FTA and the government's weakened drug-pricing policy, said Moon Kyung-tae, vice chairman of the Korea Pharmaceutical Manufactu...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK